Funding Round
Insightec raises $150M Series F to accelerate focused ultrasound adoption globally
Wall Street Journal3/25/2026·03/25/26🌐 Europe
Summary
Insightec secured $150M Series F led by Koch Disruptive Technologies, with Perceptive Advisors, MSD Capital, and Deerfield Management. The company has now raised over $480M total and is valued at approximately $1.7B. Funds will build 200 new Exablate Neuro treatment center partnerships globally and support bilateral Parkinson's FDA expansion.
Why it matters
Insightec's $1.7B valuation makes it one of the few neurotech companies at genuine unicorn scale. Their FDA expansion to bilateral Parkinson's treatment will double the addressable patient population, and 200 new treatment centers represents a major commercial infrastructure buildout.
#Focused Ultrasound#Industry#Israel#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in